Clinical trial
Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue…
NCT00194766 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00194766 |
|---|---|
| Title | Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer |
| Official title | Continuous Temozolomide (SCH 52365) in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer, Phase II |
| Lead sponsor | University of Washington, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Soft Tissue Sarcoma |
| Intervention type | Drug |
| Interventions | Temozolomide |
| Enrollment | 35 |
| Start date | Jul 1, 2000 |
| Completion | Dec 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 14, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: